Skip to main content
SpringerLink
Log in

Correspondence

  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. AMRAD Pharmaceuticals Pty. Ltd., Kew, Victoria, Australia

    Michael Wonder

  2. Clinical Research Department, Lilly S.A., Madrid, Spain

    José A. Sacristán, Elena Bolaños & Jesús M. Hernández

  3. Medical Department, Upjohn Farmoquímica, S.A., Madrid, Spain

    Javier Soto

  4. Regional Health Service, Madrid, Spain

    Inés Galende

Authors
  1. Michael Wonder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. José A. Sacristán
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Bolaños
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jesús M. Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Javier Soto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Inés Galende
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wonder, M., Sacristán, J.A., Bolaños, E. et al. Correspondence. Pharmacoeconomics 11, 287–291 (1997). https://doi.org/10.2165/00019053-199711030-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199711030-00009

Keywords

Search

Navigation